The preserved bone mass observed in participants taking liraglutide and exercising was seen despite weight reduction levels similar to outcomes with semaglutide and tirzepatide.

Biosimilars to Denosumab Win FDA Approval as Amgen and Sandoz Go to Court / image credit osteoporosis progression: ©crevis/stock.adobe.com

By Laura Joszt, MA

March 6th 2024

Biosimilars Wyost and Jubobonti were approved as interchangeable for Xgeva and Prolia but launch will depend on the outcome of litigation between reference product manufacturers.

Daily Dose: Lack of Osteoporosis Screening, Treatment in Patients with Cirrhosis

By Sydney Jennings

January 19th 2024

Your daily dose of the clinical news you may have missed.

Screening and Treatment for Osteoporosis Lacking in Patients with Cirrhosis, According to Real-World Analysis / Image credit: ©RFBSIP/AdobeStock

Screening and Treatment for Osteoporosis Lacking for Persons with Cirrhosis, According to Real-World Analysis

By Sydney Jennings

January 12th 2024

Less than a quarter of persons with cirrhosis who are diagnosed with osteoporosis are started on treatment, reported researchers.

Advertise

Terms and Conditions

Privacy

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777